[The following is a paid advertisement.]

Foreign drugmakers are lying about the 340B bill. Why? The answer is all too obvious: Big Pharma is all about protecting their profits. Anyone who’s had sticker shock when paying for medications knows this. And our elected officials know this; in fact, a U.S. Senate committee recently issued a scathing report on how drugmakers jack up new drug prices and overcharge Americans.

HB 2371 SA 2 is desperately needed legislation that will help over 100 Illinois hospitals serving low-income and uninsured patients to pass on discounted drug prices to their patients and invest in needed healthcare services. These hospitals include Safety Net providers like Sinai Chicago and Critical Access Hospitals, as well as UChicago Medicine, the state’s No. 1 provider of Medicaid services.

Here’s the truth about 340B:

• HB 2371 SA 2 does NOT expand the 340B program.
• HB 2371 SA 2 does NOT require a state appropriation.
• Similar laws were passed 20 states and upheld by the courts.
• HB 2371 SA 2 implements strong transparency requirements.

In just one year, three Big Pharma drugmakers had combined profits of nearly $39 billion, with executive salaries at nearly $154 million. Foreign drugmakers are investing in themselves, not communities. Say NO to Big Pharma and YES to Illinois hospitals and the jobs and care they provide. Learn more.